drugset / Trial / NCT01852019
Cangrelor Prasugrel Transition Study
RandomizedSingle-groupOpen-label
Summary
To demonstrate that patients treated with cangrelor can be directly switched to oral prasugrel and that patients treated with prasugrel can be switched to cangrelor without a significant decrease in the extent of inhibition of platelet aggregation.
Timeline
- Start
- 2013-06
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cangrelor | Small molecule | 4 ug/kg | Intravenous |
| Subject | Prasugrel | Small molecule | 10 mg | Oral |